Patents by Inventor Douglas Batt

Douglas Batt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20070032526
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
    Type: Application
    Filed: October 10, 2006
    Publication date: February 8, 2007
    Inventors: Peroy Carter, Robert Cherney, Douglas Batt, John Duncia, Daniel Gardner, Soo Ko, Anurag Srivastava, Michael Yang
  • Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
    Publication number: 20050227960
    Abstract: The present application describes modulators of MCP-1 of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein X, Z, a, b, c, d, n, R1, R2, R3, R4, R5, R10, R10a, and R12, are as defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using said modulators are disclosed.
    Type: Application
    Filed: February 17, 2005
    Publication date: October 13, 2005
    Inventors: Douglas Batt, Percy Carter
  • Substituted fused bicyclic amines as modulators of chemokine receptor activity
    Publication number: 20050197373
    Abstract: The present application describes modulators of CCR3 of formula (Ia) and (Ib): or pharmaceutically acceptable salt forms thereof, wherein Z, R1, R2, R3, R4, R5, R5?, R6, a, b, c, d, and u are as defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using said modulators are disclosed.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 8, 2005
    Inventors: Douglas Batt, Percy Carter, Dean Wacker
  • Substituted spiro azabicyclics as modulators of chemokine receptor activity
    Publication number: 20050197325
    Abstract: The present application describes modulators of CCR3 of formula (Ia) and (Ib): or pharmaceutically acceptable salt forms thereof, wherein Z, R1, R2, R3, R4, R5, R5?, R6, a, b, c, d, and u are as defined herein. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using said modulators are disclosed.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 8, 2005
    Inventors: Douglas Batt, Dean Wacker, George De Lucca
  • Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
    Publication number: 20050192276
    Abstract: The present application describes modulators of MCP-1 of formula (I): or stereoisomers or pharmaceutically acceptable salts thereof, wherein X, Z, a, b, c, d, bond g, n, s, R1, R2, R4, R5, R10, R12, and R13, are as defined above. In addition, methods of treating and preventing inflammatory diseases such as asthma and allergic diseases, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis using said modulators are disclosed.
    Type: Application
    Filed: February 17, 2005
    Publication date: September 1, 2005
    Inventors: Douglas Batt, Percy Carter
  • N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
    Publication number: 20050153970
    Abstract: The present application describes modulators of chemokine receptors of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: November 12, 2004
    Publication date: July 14, 2005
    Inventors: Soo Ko, Douglas Batt, George Delucca, John Duncia, Daniel Gardner, Joseph Santella
  • Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
    Publication number: 20050054626
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
    Type: Application
    Filed: August 19, 2004
    Publication date: March 10, 2005
    Inventors: Percy Carter, Robert Cherney, Douglas Batt, Gregory Brown, John Duncia, Daniel Gardner, Michael Yang
  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20050054627
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
    Type: Application
    Filed: August 19, 2004
    Publication date: March 10, 2005
    Inventors: Percy Carter, Robert Cherney, Douglas Batt, John Duncia, Daniel Gardner, Soo Ko, Anurag Srivastava, Michael Yang